Cytokines, particularly pro-inflammatory mediators, such as tumor necrosis factor-alpha (TNF-α), interleukin (IL) -1, IL-6, and IL-17 are central to RA progression by amplifying inflammatory responses and tissue damage (Kugler et al., 2023). Here, IL17A is linked to rheumatoid arthritis.